Vectors suitable for delivery of therapeutic genes to the CNS for chronic neurodegenerative diseases will require regulatable transgene expression. In this study, three self-regulating rAAV vectors encoding humanized green fluorescent protein (hGFP) were made using the tetracycline (tet)-off system. Elements were cloned in different orientations relative to each other and to the AAV internal terminal repeat (ITRs). The advantage of this vector system is that all infected cells will carry both the 'therapeutic' gene and the tet-regulator. To compare the efficiency of the vectors, 293T cells infected by each vector were grown in the presence or absence of the tet-analog doxycycline (dox). Cells were analyzed by flow cytometry for hGFP protein expression, and quantitative RT-PCR (QRT-PCR) for levels of hGFP mRNA and the tet-activator (tTA) mRNA. In the presence of dox, cells infected with one of the vectors, rAAVS3, showed less than 2% total fluorescent intensity and mRNA copy number than cells grown without dox. The other two vectors were significantly more leaky. Levels of tTA mRNA were not affected by dox. The S3 vector also displayed tight regulation in HeLa and HT1080 cells. To assess regulation in the brain, the S3 vector was injected into rat striatum and rats maintained on regular or dox-supplemented water. At 1 month after vector injection, numerous positive cells were observed in rats maintained on regular water whereas only rare positive cells with very low levels of fluorescence were observed in rats maintained on water containing dox. The QRT-PCR analysis showed that dox inhibited expression of hGFP mRNA in brain by greater than 99%. These results demonstrate that exceedingly tight regulation of transgene expression is possible using the tet-off system in the context of a self-regulating rAAV vector and that the specific orientation of two promoters relative to each other and to the ITRs is important. Regulatable vectors based on this design are ideal for therapeutic gene delivery to the CNS.
Introduction
The remarkable potential for vector-mediated delivery of therapeutic genes to treat neurodegenerative diseases and injuries to the CNS is well recognized. [1] [2] [3] [4] However, an important consideration in applying gene delivery to the CNS is the effect on the patient that may result from chronic, continuous expression in the brain of a biologically active molecule that could affect cells in addition to the target cells. This consideration is particularly relevant for neurotrophic factors since these are secreted molecules whose receptors are often widespread in the CNS. Therefore, an ideal vector for in vivo gene therapy for neurodegenerative diseases would include not only the ability to effectively and safely transduce the therapeutic gene into the CNS, but also the ability to temporally regulate gene expression.
Although several regulatable promoter systems are available for transgene regulation in mammalian cells, few of these have been studied in the context of viral vectors. Here, we report on the efficacy of the repressible tetracycline (tet) system in the context of a self-regulating recombinant adeno-associated virus (rAAV). The tet response element-based system, first described by Gossen and Bujuard, 5 is to date the best-characterized and well-studied regulated promoter system. Since the elements required for this system are derived from a prokaryotic organism, there is no endogenous expression possible in mammalian cells. 6 In addition, the effector doxycycline (dox), a tet derivative, is an FDA approved drug that can regulate the transgene expression at very low concentrations without producing detectable side effects. 7, 8 Activation of the tet-regulated promoter by dox is dose-dependent and transgene expression can be controlled over a narrow window of dox concentrations. 9 Another advantage of this system, particularly for cloning into rAAV which has a limited insert size of approximately 4.5 kb, is that the genes that encode the tet repressor and inducible promoter are small compared to the elements required for other systems.
The tet inducible system consists of two components, the tet-controlled transactivator protein (tTA), and the tet-regulated element (TRE). The tTA is a fusion protein of the tet repressor DNA binding domain of Escherichia coli (TetR) and the C-terminal transcriptional activator domain of the VP16 protein from herpes simplex virus. The TRE region consists of seven copies of the tetracycline resistance operator binding sites and a minimal cytomegalovirus (CMV) promoter region that contains the TATA box and transcription start sites. In the absence of tet or dox, tTA can bind the tetO sequence located in front of the minimal promoter and stimulate the transcription of the transgene. Dox prevents this binding and consequently abolishes transcription because the minimal promoter by itself is inactive. This tet-off system has also been modified to make a tet-on system. When the tTA is replaced by a mutated transactivator, rtTA, the promoter regulation by the transactivator is reversed so that transgene expression occurs in the presence of dox and is shut off in the absence of dox. 5, 9, 10 The tet-off and tet-on systems have been studied in the context of various viral vectors. In some cases, the two components of the tet system have been cloned into separate viruses, which requires coinfection of the target cells by both viruses to obtain regulatable transgene expression. [11] [12] [13] [14] [15] [16] Another strategy is to combine both components into one self-regulating virus so that target cells only need to be infected by one virus to allow regulatable expression. 7, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] Recombinant adeno-associated viral (rAAV) vectors have several properties that make them one of the most promising vehicles for gene delivery to the CNS. 27 These vectors have been reported to infect and transduce both dividing and nondividing cells, including neurons, with minimal cellular toxicity or host immune response. 27 In the CNS, significant long-term transduction of neurons by rAAV has been observed for up to 1 year. 25, 28 Until recently, however, the use of rAAV was hampered by the lack of methods for producing high titer vectors that were not contaminated with adenovirus or herpes simplex virus. With the development of helper virus-free packaging systems 29, 30 and a new purification protocol, 31,32 the production of large-scale high titer rAAV free of contaminating helper virus has become routine. However, the limited insert size in rAAV for foreign genes makes it difficult to design a tet-regulatable vector with an insulator region between the two tet expression cassettes to minimize promoter activity originating from the ITRs which are necessary for rAAV packaging. 24, 33 This limitation may result in leaky regulation in the context of vector backbone. In the present study, we constructed three vectors that represent all three possibilities for the orientations of the two tet expression units relative to each other and to the two ITRs. Humanized green fluorescent protein (hGFP) was used as the reporter gene. Transgene expression in the presence and absence of dox was assessed quantitatively at the protein and mRNA levels by flow cytometry and QRT-PCR in vitro. The vector with the lowest background expression as assayed in vitro was further evaluated in the striatum of rats in vivo. As far as we are aware, this is the first application of real-time RT-PCR to assess vector regulation.
Results

Vector design and characterization
The tet-activator and TRE-driven hGFP were incorporated in rAAV2 to make vectors rAAVS1, rAAVS2 and rAAVS3 containing all three possible orientations for the expression cassettes, as shown in Figure 1 . In rAAVS1, the expression cassettes are driven away from each other. In rAAVS2, the expression cassettes have the same orientation. In rAAVS3, the expression cassettes are driven away from each ITR toward each other. The distance between promoters is greatest in the case of rAAVS3 followed by rAAVS2 and rAAVS1. Prior to making virus, the expression of hGFP from all the constructs was verified by transient transfection of the shuttle plasmids and visualization of fluorescent cells (data not shown).
In vitro regulation of transgene expression at the protein level by flow cytometry
To evaluate the regulation of hGFP transgene expression, the recombinant AAV2 viruses (rAAVS1, rAAVS2 and rAAVS3) were used to infect wtAd5 superinfected 293T cells at MOI 100. At 4 h after viral infection, 2 mg/ml of dox was added to half the wells (n ¼ 3) to suppress the hGFP expression, and the remaining cells were allowed to grow in normal medium to allow maximal expression of hGFP. Figure 1 Schematic representation of the three self-regulated rAAV vectors. All three constructs are flanked by the ITRs (internal terminal repeat) of rAAV2 at both ends. In rAAVS1, the expression cassettes are driven away from each other. In rAAVS2, the expression cassettes have the same orientation. In rAAVS3, the expression cassettes are driven away from the ITRs toward each other. The distance between promoters is highest in rAAVS3, followed by rAAVS2 and rAAVS1. CMV, cytomegalovirus promoter. tetR, tetracycline response protein. VP16, the C-terminal 127 amino acids of the herpes simplex virus VP16 activation domain. P CMV , minimal CMV promoter. TRE, tetracycline response element. SV40 pA, Simian virus 40 polyadenylation signals. hGFP, humanized R. reniformis green fluorescent protein.
Tightly self-regulated tet-off rAAV L Jiang et al transduction (Po0.001, Figure 3a ). Cell infected with rAAVS3 showed the lowest level of background expression in the presence of dox, 0.65% at 1 day, 2.13% at 3 days and 0.54% at 5 days postinfection (Figure 3b ). In contrast, rAAVS2 conferred high background expression, 15.90% at 1 day, 29.95% at 3 days and 36.67% at 5 days (Po0.001, rAAVS2 versus rAAVS3 at all three time points). The ability to regulate transgene expression from rAAVS1 was in between rAAVS3 and rAAVS2 (Po0.001, rAAVS1 versus rAAVS3 at 3 and 5 days. Figure 3b) . A dose-response curve of dox regulation from S3 was also generated. This showed that this self-regulated vector displayed dose-dependent regulation as has been reported for the tet-off system at the plasmid level (Figure 3c) . 10 In addition to testing these vectors in 293T cells at MOI 100, we also tested the rAAVS3 vector at 10 and 300 MOI on 293T cells with similar results and at 100 MOI on both Hela and HT1080 cell lines. Levels of expression were lower in these cell lines due to the absence of helper virus, but S3 also conferred the tightest regulation similar to that observed in 293T cells as assessed by flow cytometry (data not shown).
Based on the sorted rAAVS3-infected stable cell line, transgene expression was consistently on before addition of inducer. However, up to 99% of the transgene expression could be turned off by 7 days when these cells were exposed to the inducer (2 mg/ml of Dox) continuously (Figure 3d ).
In vitro regulation of transgene at mRNA level To correlate the decrease in level of hGFP protein with mRNA depletion, we evaluated the number of copies of hGFP mRNA by QRT-PCR with the RNA samples isolated from the same cells used for FACS analysis. At the mRNA level, the highest level was at 5 days after the infection in all the groups (Po0.001, Figure 4a ). The level of inhibition by dox at the mRNA level for all three vectors was similar to that of protein depletion ( Figure  4b ). Background expression was lowest in cells infected with rAAVS3, whereas cells infected with rAAVS2 had the highest degree of background expression. However, the degree of inhibition from rAAVS2 was a little lower at the RNA level than at the protein level, while the other two viruses had approximately the same level of inhibition at both the protein and RNA levels.
Evaluation of tTA expression at the mRNA level
The level of tTA gene product is one of the important factors contributing to the effectiveness of the tetracycline inducible system. Judging from the protein and mRNA assays of hGFP expression, the three vector designs appear to differ in degree of regulation. These differences may be caused by the distance between the two promoters in the constructs or by differences in the level of tTA. To address this, we sequenced the entire tTA gene in all three constructions and verified that no point mutations existed. Then, QRT-PCR was used to assay the mRNA level of tTA at three time points in cells grown in the presence or absence of dox ( Figure 5 ). Similar to the hGFP mRNA level, all three vectors have the highest level of tTA mRNA level at 5 days treatment ( Figure 5a ). The ratio of tTA copy number in 'ON' versus 'OFF' condition was 0.97 for rAAVS3 at 1 day, and 0.92 and 0.97 for 3 and 5 days, respectively. The ratio for rAAVS2 ranged from 0.93 at 3 days to 2.11 at 5 days, whereas that of rAAVS1 ranged from 2.34 at 3 days to 5.05 at 5 days. Therefore, the ratios of the level of tet expression in the 'ON' and 'OFF' states in these three viruses in which the tTA is driven by the CMV promoter are relatively stable (P40.05 among the three tested time points, Figure 5b ).
In vivo regulation of transgene expression in brain by QRT-PCR
Since the results from the in vitro studies showed that the rAAVS3 had the lowest background expression of transgene, the efficiency of regulation from this vector was studied in vivo in the CNS. Striata of six rats were injected bilaterally with 3 ml of rAAVS3 and half the rats maintained on regular water ('ON' group) and another half administrated dox (2 mg/ml) containing water right after the surgery ('OFF' group). After 1 month, transgene expression was studied in one striatum by histology and in the contralateral striatum by QRT-PCR. Numerous positive cells with very bright fluorescence (39 5467 6435/striatum n ¼ 3) were observed in a widespread area of striatum of 'ON' rats ( Figure 6a ), whereas only rare bright positive cells (218873363/striatum) were observed in 'OFF' rats ( Figure 6b ). This is about 95% depression of transgene expression in terms of positive QRT-PCR analysis showed that there were 1.58970.56 Â 10 7 copies of hGFP per 10 4 copies of bactin in the 'ON' group (n ¼ 3). In contrast only 9.970.57 Â 10 4 copies of hGFP per 10 4 copies of b-actin were found in the striata of OFF' rats or less than 1% of the expression level in the absence of dox (Figure 6d,e) .
Discussion
We applied real-time QRT-PCR and flow cytometry to quantitatively assess transgene regulation from a tet-off system in the context of a rAAV serotype 2 vector. Three self-regulating rAAV vectors, rAAVS1, S2 and S3, which differ only in the orientation of the expression cassettes for the cellular marker hGFP and the tTA regulator, were compared and found to have markedly different levels of leakiness. The S3 design, in which the two expression cassettes are driven toward the middle of the construct and away from the ITRs, was by far the most tightly regulated, with levels of hGFP protein and mRNA in infected cells grown in the presence of dox less than 2% of those in control cells. The S3 vector was also effectively regulated in striatum of rat brain by peripheral administration of dox. The differences among S1, S2 and S3 vectors could not be accounted for by differences in levels of tTA expression since QRT-PCR showed relatively stable expression of tTA mRNA over time in cells infected with each vector. The application of real-time QRT-PCR has permitted more rigorous assessment of these self-regulated rAAV vectors than methods generally employed. Previous studies of the tet-off system have primarily assessed gene expression by looking at transgene protein. The inherent disadvantage of using this method for the commonly used reporter gene, GFP, is that this protein has a long intracellular half-life. 34 The efficiency of a regulatable promoter can be more readily assessed by looking at mRNA levels. An interesting finding revealed by these quantitative data is that even with a vector that can be shut off at levels greater than 99%, the number of copies of transgene mRNA remaining in the brain may still be significant depending on the initial dose of vector injected.
There are two approaches to utilize the tet-off system in the context of rAAV. One is to incorporate expression cassettes for the transactivator tTA and the transgene driven by tet-regulated promoter into two separate viral vectors. 15 Modulation of gene expression using two separate rAAV vectors requires cells being infected by both vectors because tTA protein is not expected to diffuse between cells. A more effective approach is to clone both expression cassettes into a single self-regulating vector. 24, 26 In the self-regulating strategy, a tetcontrolled activator strongly activates transcription from a minimal CMV promoter in the absence of dox. All cells infected with a self-regulating vector will express both activator and transgene. This may be important for gene delivery and regulation in brain since no cells would Tightly self-regulated tet-off rAAV L Jiang et al carry the transgene without the regulator as would be the case for a two-vector system. Another advantage of a self-regulating vector is that a lower amount of virus is needed to obtain comparable transgene expression than with a two-vector system. While the single selfregulating rAAV strategy seems advantageous over a two-vector system, previous studies have not assessed quantitatively the effectiveness of tet-regulation from such vectors at the level of mRNA. Several parameters have been described that could affect transgene expression and degree of leakiness in viral vectors harboring tet-regulated constructs, such as the level of tTA during basal and repressed expression states, the ratio of the inducible construct to the transactivator unit, and the space between the two expression units in the self-regulating model. 10 In the self-regulating vectors designed in this study, the ratio of inducible construct to transactivator expression should theoretically be the same among vectors, as well as constant over time. Interestingly, the absolute levels of tTA mRNA and hGFP mRNA differed substantially among the vectors. While cells were infected with equivalent amounts of virus, the highest levels of expression of both tTA and hGFP were observed in cells infected with the S1 and S2 vectors. In contrast, the level of hGFP expression in cells grown in the presence of dox, that is, the degree of leakiness, was significantly lower in cells infected with the S3 vector. Moreover, in cells infected with three vectors, the ratio of copy number of tTA mRNA in the absence of dox to tTA mRNA in the presence of dox varied between 1 and 5, suggesting that the CMV promoter activity is influenced by precise vector configuration. Nevertheless, turning off hGFP expression with dox had no effect on expression of the tTA activator.
This study shows that the inducible self-regulatable viral vector, rAAVS3, has low basal and high inducible levels of both transgene protein and mRNA. The level of leaky expression is about 1%. This level is comparable to other types of viral vector systems harboring a selfregulated tet-off system. Two different groups have tested the same design as rAAVS3 in retroviral vectors, Tightly self-regulated tet-off rAAV L Jiang et al where the two components of the tet-off system were organized within the vectors in a manner that stringently maintained tet-dependent regulation. These studies showed between 24-and 127-fold increases in transgene expression levels compared to the 'OFF' state. 35 Retroviral vectors for the controlled expression of nerve growth factor and GFP based on the tet-off system demonstrated 36-to 52-fold activation of transgene expression as measured by ELISA. 34 For the rAAVS3 vector, we observed a 90-fold induction of both protein and mRNA.
In the rAAVS3 vector, the expression cassettes are driven in opposite orientations, which likely reduces promoter interference. This observation is supported by other studies where a stuffer region was introduced to prevent transcriptional interference. Generation of a single adenoviral vector encoding human tyrosine hydroxylase (TH-1), a transcriptional interference sequence and tTA, resulted in a high level of TH enzymatic activity in striatum which was nearly abolished by dox treatment. 7 In another recent study, the tet-off system was evaluated in rAAV vectors using a bidirectional promoter to drive the expression of tTA and EGFP. In this system, a low level of transgene protein was observed when the vector was turned off, while a rapid induction of expression was observed when turned on. The increase of transgene expression ranged from 100-to 138-fold under in vitro conditions and 49-to 204-fold under in vivo conditions. That study did not assess regulation from the vector at the mRNA level, but at the protein level, it was similar to the rAAVS3 vector reported here. Another study showed that transgene protein expression from a self-regulated rAAV vector, in which tTA is itself under the control of a tet-regulated promoter, rather than the CMV promoter as in rAAVS3, could be tightly regulated both in vivo and in vitro for long term. 26 However, toxicity has been reported for this vector possibly resulting from the high level of tTA expression. 36 The exact mechanism responsible for the observed differences in degree of regulation among the rAAVS1, S2 and S3 vectors remains to be elucidated. The distance between the two promoters might be one factor underlying these differences. As the distance increases between the promoters, interference between promoter activities may be minimized. This suggestion is Tightly self-regulated tet-off rAAV L Jiang et al supported by the observation that the addition of an 'insulator' between the two expression cassettes can improve the precise regulation of the transgenes. 9, 10 Another factor affecting expression may be the promoter activity of the ITRs, as previously reported. 33 This could increase or decrease both inducible and basal expression levels of the transgene depending on vector configuration. In rAAVS1 and S2, where the expression cassette and the flanking ITR are opposed presumably resulted in some interference of ITR activity on the minimal promoter resulting in a higher degree of leakiness. In rAAVS3, both expression cassette promoters were in the same direction as the flanking ITRs, thus minimizing this interference. The design of rAAVS3 might be further improved by the addition of insulators between the ITRs and the expression cassettes to further block any residual promoter activity of the ITRs. 24 QRT-PCR showed the background expression in the brain from the S3 vector was somewhat less than observed in vitro as determined by the hrGFP mRNA copy number normalized against b-actin. Interestingly, even though hGFP transgene expression could be turned off by 99.4% at the mRNA, this level was found to be about 10-fold higher than that of b-actin mRNA, which was used as the internal control for our experiments. This raises a cautionary note when considering regulated vectors for clinical use in the CNS. Even a vector that is extremely well regulated with less than 1% of leakage in the 'OFF' state might leave a sufficient level of transgene protein to confer biological activity. A number of variables would enter into this possibility such as the original titer and distribution of the vector injection, the half-life and kDa of the protein, and the distribution of the protein in the CNS. Studies are presently in progress to further address this possibility using a biologically active transgene rather than the current reporter gene hrGFP.
In summary, we have rigorously evaluated several self-regulating rAAV vectors expressing the hrGFP transgene under a tet-regulated promoter using quantitative methods to follow both transgene and activator expression. One of these vectors, the rAAVS3 vector was found to be tightly regulated and to express low, stable levels of activator. This vector may be ideal for clinical trials for gene delivery to the CNS.
Materials and methods
Animals
Adult Fischer 344 rats (150-200 g) were obtained from Harlan (Indianapolis, IN, USA), housed in the Children's Memorial Institute for Education and Research vivarium. Food and water were available ad libitum during a 12-h light/dark cycle and animals were treated according to institutional and NIH guidelines.
Construction of self-regulated rAAV shuttle vectors
The pBR322-based AAV shuttle vector pTR (a generous gift from Mark Sands, Washington University School of Medicine) was digested with PstI and blunted by the large fragment of T4 DNA polymerase. A 1.6 kb fragment was isolated and ligated into the KpnI and NotI digested and blunted sites of pBluescript KS þ to make the pBSTR. This is a high copy number shuttle plasmid, which contains two inverted terminal repeats (ITR) of AAV2 and an intervening stuffer region between the two ITRs. To make the self-regulated shuttle plasmids, some intermediate plasmids were made in pSP72 (Promega Corporation. Madison, WI, USA) and then appropriate expression cassettes were transferred into the pBSTR to replace the stuffer region. First, the EcoRI and SspI (blunted) IREShGFP fragment from pIRES-hGFP-1a (Stratagene, La Jolla, CA, USA) was inserted into the EcoRI and EcoRV sites of pSP72 to make pSP72IREShGFP. The TRE fragment was cut out of pTRE-2 (Clontech, Palo Alto, CA, USA) with XhoI blunt-ended, and then cut with EcoRI. This fragment was ligated into the SmaI and EcoRI sites of pSP72IR-EShGFP to make pSP72TREIREShGFP. EcoRI and BstXI were used to remove the IRES fragment from this plasmid to produce pSP72TREhGFP. The blunted XhoI and PvuII tTA expression unit from plasmid pTet-Off (Clontech, Palo Alto, CA, USA) was ligated into the blunted BamHI site of the pSP72TREhGFP to make the pSP72ALL-. Following digestion of pSP72ALL-with BglII and XhoI, the ALL-double cassette was transferred into the blunted BglII sites of the pBSTR to make pAAVS1. To make the two other configurations of selfregulating shuttle plasmids pAAVS2 and pAAVS3, another intermediate plasmid pBSTRTet-Off was made first. The blunted XhoI and PvuII tTA expression unit from pTet-Off was inserted into the SmaI and EcoRV sites of the pSP72 to derive plasmid pSP72tTA. BamHI and BglII were then used to cut the CMVtTA fragment from pSP72tTA and insert it into the BglII sites of pBSTR to produce pBSTRTet-Off. The BglII and Xho TREhGFP from pSP72TREhGFP was blunted into the HindIII site of pBSTRTet-Off to make pAAVS2 and pAAVS3.
Recombinant AAV vector production
The components needed for the production of recombinant AAV-2 particles in the helper virus-free system include a shuttle plasmid containing the gene of interest and the AAV-2 ITRs, the pDG plasmid 29 (generously provided by Juergen Kleinschmidt, University of Heidelberg) and 293T cells. Recombinant AAV (rAAV) vectors were packaged and purified as described previously with minor modifications. 32 In brief, 293T cells were plated at 2 Â 10 6 cells per 100-mm tissue culture plate in 10 ml DMEM containing 10% FBS and antibiotics 48 h prior to transfection. Shuttle and pDG plasmids were used at a ratio of 1:3 for CaCl 2 transfection. At 2-4 h before transfection, fresh, prewarmed medium was added to the 293T cells and then the DNA/CaCl 2 / HEPES suspension was added dropwise, swirling gently to distribute the DNA suspension evenly. After 48 h, the medium was replaced with 10 ml of fresh DMEM growth medium and plates were incubated for another 24 h. After 72 h incubation, the cells were harvested into 50-ml falcon tubes and 15 ml lysis buffer (50 mM Tris-HCl (pH 8.5) and 150 mM sodium chloride) was added to 20 plates worth of cells. The cell suspension was subjected to three rounds of freeze/thawing by alternating tubes between a dry ice-ethanol bath and a 371C water bath, vortexing briefly after each thaw. Following centrifugation at 10 000 g for 10 min at room temperature, the supernatant was transferred to a fresh tube and 4 ml of benzonase (50 U/ml) was added to the cell suspension. After incubation at 371C for 30 min, the lysate was clarified Tightly self-regulated tet-off rAAV L Jiang et al by centrifugation at 5000 g for 10 min and the crude viral lysate loaded onto a 15-60% iodoxanol step gradient and centrifuged at 69 000 rpm for 1 h and 20 min at 181C. After centrifugation, 4 ml of the 40% fraction was collected by puncturing the sidewall of the ultracentrifuge tube with an 18G needle. This fraction was loaded onto heparin-agarose column, which was preequilibrated with 20 ml PBS-MK buffer (1 Â phosphatebuffered saline (PBS), 1 mM MgCl 2 and 2.5 mM KCl). The rAAV particles were eluted with 4.0 ml PBS containing 1 M NaCl and concentrated using an Ultrafree-4 BioMax-100 membrane. After concentrating the sample to 0.5 ml and dialyzing the sample overnight against PBS, the rAAV vector capsid particle number was determined using an ELISA kit (Progen Biotechnik GMBH, Heidelberg, Germany) based on the A20 capsid protein and checked for in vitro expression of GFP using 293T cells. The final particle titer of rAAVS1 was 4.0 Â 10 12 viral particles per milliliter, 1.3 Â 10 12 viral particles per milliliter for rAAVS2, 1.8 Â 10 12 viral particles per milliliter for rAAVS3.
For the in vivo studies, rAAVS3 vectors were purified by FPLC. In brief, the lysate of harvested cells was applied to a POROS-PI ion-exchange column (Waters, Inc.) and then eluted with 350 mM potassium chloride. 37 The eluant was then applied to a HiTrap heparin column (Amersham, NJ, USA) and eluted with a zero to 1 M sodium chloride gradient. 31 The buffer was exchanged to PBS and vector stocks concentrated using a CentriPlus 100 000 MW cut-off filter. The titer of the final stock was measured by Q-PCR as described elsewhere. 38 
Viral infection and hGFP regulation by dox under in vitro conditions
One day before infection, wild-type adenovirus type 5 (wtAd5) infected 293T cells were seeded at 0.5 Â 10 6. cells/well in six-well plates in 2 ml of 10% FBS containing DMEM and incubated overnight at 371C. Before virus infection, an appropriate amount of virus was diluted in 1 ml of 2% FBS containing DMEM. The old medium was replaced with the virus-containing medium, and the cells were then incubated at 371C. After 4 h, either 1 ml of 2% FBS DMEM was added to the wells for 'ON' condition or 2% FBS and 2 mg/ml of dox in DMEM was added for the 'OFF' condition. Thereafter, the cells were incubated at 371C and the medium was changed every 2 days until the cells were harvested. Flow cytometry was used for quantitative analysis of hGFP protein expression.
At the desired time point, the cells were harvested and resuspended in PBS at about 10 6 cells/ml. The percent of fluorescent cells and total fluorescence intensity were determined using a Becton Dickinson (San Jose, CA, USA) FACScan to analyze the hGFP expression. The results are reported as total fluorescence intensity.
Time course to turn-off transgene expression based on rAAVS3-infected stable cell line in vitro
The 293 cell line at 60-70% cell density was infected by rAAVS3 and maintained in normal DMEM medium. The cells were applied to the Beckman Coulter Elite ESP flow cytometer for cell sorting 48 h after the viral infection. The hGFP-positive cells were collected and expanded in normal DMEM medium. For a time course of transgene turn-off, cells were seeded into six wells plates at varying densities so that cells would attain approximately the same density at each time point after growth for 1, 3, 5 or 7 days in medium containing 2 mg/ml of Dox. Cells were then collected, fixed in 4% PFA and resuspended in PBS buffer for flow cytometry.
Histology and microscopy
All surgical procedures were performed with the rats under isofluorane gas anesthesia using aseptic procedures. After a rat was anesthetized, it was placed in a Stoelting stereotaxic apparatus and 3 ml rAAVS3 (2 Â 10 12 viral genome/ml) were injected into the striatum bilaterally. The coordinates were: AP: 1.0 mm, ML: 2.8/ À2.8 mm and DV:À5.0 mm. After the skull was exposed, a burr hole was made with a dental drill above the injection site. The injection rate was 0.5 ml/min using a 10 ml syringe with 30G needle (Hamilton, Reno, NV, USA). The needle was retained for 5 min before being withdrawn at 1 mm/min. The skin and soft tissue were sutured and then the rats returned to the vivarium. For studies of regulation, three rats were provided with regular drinking water and another three with water containing doxycycline (2 mg/ml) (Sigma, St Louis, USA) right after surgery. After 4 weeks, rats were killed under anesthesia (213 mg chloral hydrate and 44 mg sodium pentobarbital per kilogram body weight i.p.). The brain was removed and cut in half sagittally.
The striatum of one hemisphere was quickly microdissected under a microscope (Wild M7A, Switzerland), frozen on dry ice, and then stored at À801C for real-time PCR. The other hemisphere was fixed by immersion in 4% paraformaldehyde with 5% sucrose in PBS, and cryoprotected by sequential immersion in 10, 20 and 30% sucrose in PBS. Frozen coronal sections (40 mm) were made through the striatum using a sliding microtome and stored in cryoprotective solution at À201C. The expression of the hGFP was observed under epifluorescence. Determination of the number of hGFP-positive cells in each injected striatum was carried out using Neurolucidat software (Version 5.00, Williston, VT, USA). Briefly, every sixth section of the striatum was mounted on a precleaned microscope slide and coverslipped with FluorSave Reagent (Calbiochem, San Diego, CA, USA). The region of interest (ROI), which containing most of positive cells, was first defined using a 4 Â objective and then the counting field was switched to a 40 Â objective. The meander scan mode was chosen to systematically move the section to each field within the counting regions and positive cells were marked. The summary of count from all sections was multiplied by 6 to estimate the total positive cells in each injection site. Sections through the injection site were also stained with H&E using standard methods.
Quantitative real-time PCR (QRT-PCR).
For QRT-PCR, total RNA from cells infected in vitro with the different viruses at different time points and microdissected injected striatum were extracted using Tri Reagent (Sigma, T9424). Total RNA was treated with Rnase-free DNase I (Boehringer Mannheim) at a concentration of 1 U/mg of total RNA at room temperature for 30 min to remove the contaminating DNA followed by heat inactivation at 751C for 15 min. The possible contamination by ssDNA from the rAAV vector DNA was removed by the incubation with restriction enzyme
HaeIII (New England Biolabs, Inc., Beverly, MA, USA) at 371C for 20 min. The resulting RNA was further purified using RNA Easy Kit (Qiagen Inc. CA, USA), according to the manufacturer's instructions. Quantitative analysis of the expression of hGFP mRNA from samples was assessed using the Perkin Elmer 7700 System (Perkin-Elmer/Applied Biosystems, Inc., Foster City, CA, USA). Using this method, quantitation is achieved by the addition of a fluorescently labeled probe which anneals between the forward and reverse primers of the target gene. The probe consists of an oligonucleotide with a fluorescent reporter dye (6-carboxylfluorescein, FAM) covalently linked to the 5 0 end and a quencher carboxytetramethylrhodamine (TAMRA) linked to the 3 0 end. During each PCR cycle, the 5 0 nucleotidase activity of the Taq enzyme will release the reporter dye from the probe. This results in the release and detection of fluorescent signal from the quencher dye. This fluorescent signal increases with each PCR cycle and quantitation is based on the threshold cycle, that is, the PCR cycle in which the amplification signal is first detected to be above the baseline signal. 39 In one QRT-PCR reaction, 25 ng template RNA was added to a 96-well plate which contained the following components from TaqMan Core PCR Kit (Perkin-Elmer/ Appliedbiosystems, Inc., Foster City, CA, USA) 5 ml 10 Â TaqMan Buffer A (composed of 500 mM KCl, 100 mM Tris-HCl, 0.1 M EDTA, 600 nM passive reference dye, pH 8.3 at room temperature), 10 ml of 25 mM MgCl 2 , 1.5 ml of each dNTP (10 mM for dATP, dCTP and dGTP, 20 mM for dUTP), 0.5 ml of forward and reverse primers (10 mM), 1 ml of 5 mM TaqMan probe, 0.25 ml (12.5 U) of AmpliTaq Gold, 1 ml RNAse Inhibitor and 0.25 ml (12 U) of MMuLV. RNAse-free water was added to bring the final volume of the reaction to 50 ml. The QRT-PCR amplification conditions were 30 min at 481C, then 15 min at 951C, followed by 40 cycles of denaturation at 951C for 15 s and annealing/extension at 591C for 60 s for all three genes evaluated in this study.
To determine the copy number of hGFP mRNA in the samples, the gene hGFP was inserted into the pBluescript KS downstream of the universal T7 promoter. SmaI digestion was used to linearize the plasmid and this DNA was used as template to carry out the hGFP in vitro transcription with the AmpliScribe T7 High Yield Transcription Kit (Epicenter Inc., Madison, WI, USA). The copy number of hGFP mRNA per microgram was calculated according to the molecular weight of the hGFP sequence and Avogadro's number. Between 150 and 5 million copies of hGFP RNA were analyzed as the template in the 7700 PCR mix. This experiment was run in triplicate and the resulting threshold cycles for each known amount of hGFP were averaged and plotted to generate a regression equation. The resulting threshold cycles from in vitro samples were incorporated into this equation to obtain the number of copies of hGFP mRNA. In addition, levels of tTA mRNA and human b-actin mRNA were also analyzed and standard curves were developed in the same manner. Human b-actin was used as an internal control to normalize the results of hGFP and tTA mRNAs in each sample. Vector regulation at the mRNA level and the ratio of tTA under 'ON' condition against the 'OFF' condition were based on the normalized copy number of each sample. The sequences of the primers and probes for these three genes are listed in Table 1 . 
Statistical analysis
Data were analyzed with a one-way ANOVA followed by a Newman-Keuls test using GraphPad Prism software (Version 3.0, San Diego, CA, USA) and shown as mean7s.d. Differences between groups were considered significant at the level of Pr0.01.
